ArticleOncotarget2017

Baseline relative eosinophil count as a predictive biomarker for ipilimumab treatment in advanced melanoma.

Pier Francesco Ferrucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.